2026 NPPES data Otolaryngology Physician NPI 1609821297 M.D.
Verify on CMS →

BORIS CHERNOBILSKY, M.D.

Otolaryngology Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
407
Medicare Part D claims · 120 beneficiaries · Otolaryngology Physician avg: 509
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
84.4744/100
▲ 1 pts above national avg 83.1 · [object Object]
Industry payments
$1.2K
9 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: BORIS CHERNOBILSKY, M.D. is a Otolaryngology Physician ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 407 claims across 120 beneficiaries — 6% brand-name prescribing . Their CMS MIPS Final Score of 84.4744/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $1.2K across 9 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: BORIS CHERNOBILSKY, M.D. reported a CMS MIPS final score of 84.4744 out of 100, above the 83.1 national average, and filed 407 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

BORIS CHERNOBILSKY, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

BORIS CHERNOBILSKY, M.D. at a glance

Near national average

NPI registry status

Active

Issued 05/23/2006

NPI 1609821297

Primary specialty

Otolaryngology Physician

Mid-sized

10,895 US NPIs in this specialty

Medicare Part D claims

407 20% vs specialty avg

2023 prescription claims

Specialty avg: 509

MIPS final score

84.4744/100 1.3744000000000085% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New York

How Otolaryngology Physician compares to other specialties among New York providers

New York providers

Otolaryngology Physician share within New York

1. Otolaryngology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otolaryngology Physician share within New York

Medicare quality performance — MIPS

BORIS CHERNOBILSKY, M.D.'s 2023 MIPS final score plotted against the Otolaryngology Physician national average

Near national average
MIPS Final Score
84.4744/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Otolaryngology Physician) — 84.4744/100 vs national avg 83.1

0%100%National avg83%84.5%
MIPS final score (Otolaryngology Physician) — 84.4744/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BORIS CHERNOBILSKY, M.D. is a Otolaryngology Physician provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1609821297. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

BORIS CHERNOBILSKY, M.D. appears in the CMS NPPES registry as a Otolaryngology Physician provider holding M.D. credentials at 923 5TH AVE APT NEW, NEW YORK, NY, 10021, with a listed phone of (212) 444-8006. NPI 1609821297 was issued on 05/23/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CHERNOBILSKY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 407 prescription claims written by this provider, covering 120 Medicare beneficiaries and totaling roughly $18K in drug spend, split 6% brand-name and 94% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 84.4744/100 for the 2023 performance year (Quality 93.334, Cost 54.914), compared with the national average of 83.1.

Otolaryngology Physician is a mid-sized specialty nationwide, with 10,895 enrolled providers across 54 states and an average of 509 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

923 5TH AVE APT NEW
NEW YORK, NY 10021

Provider Details

NPI 1609821297
Specialty Otolaryngology Physician
Credentials M.D.
Gender Male
NPI Issued 05/23/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

84.4744
Final Score
Avg: 83.1
93.334
Quality
54.914
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where BORIS CHERNOBILSKY, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

INTERFAITH PROFESSIONAL PHYSICIAN SERVICES PC
BROOKLYN, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BORIS CHERNOBILSKY, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.2K

Largest payer

Inspire Medical Systems, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to BORIS CHERNOBILSKY, M.D.. To verify BORIS CHERNOBILSKY, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

BORIS CHERNOBILSKY, M.D. — brand share 6.0%
Specialty average (est.)

6% brand-name claims vs 94% generic, on 407 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

407
Total Claims
$18K
Total Drug Cost
120
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
503
Total Day Supply
13,196
Brand vs Generic
6% brand / 94% generic
Brand Drug Cost
$10K
Generic Drug Cost
$8K
Antibiotic Claims
18

Patient Demographics

Average Patient Age
69.5 years
Avg HCC Risk Score
1.39
Gender Split
46% female / 54% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Azelastine Hcl
64
Mupirocin
52
Fluticasone Propionate
46
Levocetirizine Dihydrochloride
30
Montelukast Sodium
26
Fluocinolone Acetonide Oil
20
Ipratropium Bromide
19
Armodafinil
13
Trazodone Hcl
13
Eszopiclone
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otolaryngology Physician Overview

How BORIS CHERNOBILSKY, M.D. fits within the Otolaryngology Physician landscape nationally.

10,895
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
509
Avg Claims per Provider

BORIS CHERNOBILSKY, M.D.'s 407 claims are below the specialty average of 509.

Nearby Otolaryngology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as CHERNOBILSKY.

Compare Otolaryngology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is BORIS CHERNOBILSKY, M.D.'s specialty?
BORIS CHERNOBILSKY, M.D. specializes in Otolaryngology Physician and practices in NEW YORK, New York. Credentials: M.D..
How much does BORIS CHERNOBILSKY, M.D. prescribe under Medicare Part D?
In 2023, BORIS CHERNOBILSKY, M.D. wrote 407 Medicare Part D claims totaling $18K in drug costs for 120 beneficiaries.
What is BORIS CHERNOBILSKY, M.D.'s Medicare quality score?
BORIS CHERNOBILSKY, M.D. has a CMS MIPS Final Score of 84.4744/100 (Quality: 93.334, Cost: 54.914). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is BORIS CHERNOBILSKY, M.D. located?
BORIS CHERNOBILSKY, M.D. is located at 923 5TH AVE APT NEW, NEW YORK, NY, 10021. Phone: (212) 444-8006.
What is BORIS CHERNOBILSKY, M.D.'s NPI number?
BORIS CHERNOBILSKY, M.D.'s National Provider Identifier (NPI) is 1609821297, issued on 05/23/2006.
Does BORIS CHERNOBILSKY, M.D. prescribe more brand-name or generic drugs?
BORIS CHERNOBILSKY, M.D.'s prescribing is 6% brand-name and 94% generic drugs by claim count, with $10K in brand drug costs.
How many Otolaryngology Physician providers are there in the US?
There are 10,895 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 509 Medicare Part D claims per year.
What drugs does BORIS CHERNOBILSKY, M.D. prescribe most often?
Based on 2023 Medicare Part D data, BORIS CHERNOBILSKY, M.D.'s most frequently prescribed drugs include Azelastine Hcl, Mupirocin, Fluticasone Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BORIS CHERNOBILSKY, M.D. accept Medicare?
BORIS CHERNOBILSKY, M.D. appears in CMS Medicare data with 407 Part D claims and 120 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BORIS CHERNOBILSKY, M.D.'s credentials?
BORIS CHERNOBILSKY, M.D.'s NPI is 1609821297 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology